191 Publications (Page 1 of 8)
2023
High-dose chemotherapy for relapsed testicular germ cell tumoursChovanec, Michal⋅Chovanec, Michal⋅Adra, Nabil⋅Adra, Nabil⋅Abu Zaid, Mohammad⋅Abu Zaid, Mohammad⋅Abonour, Rafat⋅Abonour, Rafat⋅Einhorn, Lawrence and Einhorn, LawrenceNature Reviews. Urology, vol. 20, (no. 4), pp. 217-225, Apr 2023.
| Journal Article
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma.Walker, Brian⋅Johnson, Travis⋅Sudha, Parvathi⋅Liu, Enze⋅Blaney, Patrick⋅Morgan, Gareth⋅Chopra, Vivek⋅Santos, Cedric Dos⋅Nixon, Michael⋅Huang, Kun⋅Suvannasankha, Attaya⋅Zaid, Mohammad Abu and Abonour, RafatResearch square, August 16, 2023.
| Journal Article
2022
High-dose chemotherapy for relapsed testicular germ cell tumours.Chovanec, Michal⋅Chovanec, Michal⋅Adra, Nabil⋅Adra, Nabil⋅Abu Zaid, Mohammad⋅Abu Zaid, Mohammad⋅Abonour, Rafat⋅Abonour, Rafat⋅Einhorn, Lawrence and Einhorn, LawrenceNature reviews. Urology, December 7, 2022.
| Journal Article
2021
Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease.Farag, Sherif S⋅Farag, Sherif S⋅Abu Zaid, Mohammad⋅Abu Zaid, Mohammad⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Schwartz, Jennifer E⋅Thakrar, Teresa C⋅Blakley, Ann J⋅Thakrar, Teresa C⋅Blakley, Ann J⋅Blakley, Ann J⋅Blakley, Ann J⋅Abonour, Rafat⋅Robertson, Michael J⋅Abonour, Rafat⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Broxmeyer, Hal E⋅Broxmeyer, Hal E⋅Zhang, Shuhong⋅Zhang, Shuhong⋅Zhang, Shuhong and Zhang, ShuhongThe New England journal of medicine, vol. 384, (no. 1), pp. 11-19, January 7, 2021.
| Journal Article
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.Hájek, Roman⋅Minařík, Jiří⋅Straub, Jan⋅Pour, Luděk⋅Jungova, Alexandra⋅Berdeja, Jesus G⋅Boccadoro, Mario⋅Brozova, Lucie⋅Spencer, Andrew⋅Rhee, Frits van⋅Vela-Ojeda, Jorge⋅Thompson, Michael A⋅Abonour, Rafat⋅Chari, Ajai⋅Cook, Gordon⋅Costello, Caitlin L⋅Davies, Faith E⋅Hungria, Vania Tm⋅Lee, Hans C⋅Leleu, Xavier⋅Puig, Noemi⋅Rifkin, Robert M⋅Terpos, Evangelos⋅Usmani, Saad Z⋅Weisel, Katja C⋅Zonder, Jeffrey A⋅Bařinová, Magda⋅Kuhn, Matyáš⋅Šilar, Jiří⋅Čápková, Lenka⋅Galvez, Kenny⋅Lu, Jin⋅Elliott, Jennifer⋅Stull, Dawn Marie⋅Ren, Kaili and Maisnar, VladimírFuture oncology (London, England), March 26, 2021.
| Journal Article
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US.Davies, Faith⋅Davies, Faith⋅Davies, Faith⋅Rifkin, Robert⋅Rifkin, Robert⋅Rifkin, Robert⋅Costello, Caitlin⋅Costello, Caitlin⋅Costello, Caitlin⋅Morgan, Gareth⋅Morgan, Gareth⋅Morgan, Gareth⋅Usmani, Saad⋅Usmani, Saad⋅Abonour, Rafat⋅Abonour, Rafat⋅Palumbo, Antonio⋅Palumbo, Antonio⋅Palumbo, Antonio⋅Romanus, Dorothy⋅Romanus, Dorothy⋅Hajek, Roman⋅Hajek, Roman⋅Hajek, Roman⋅Terpos, Evangelos⋅Terpos, Evangelos⋅Cherepanov, Dasha⋅Cherepanov, Dasha⋅Stull, Dawn M⋅Stull, Dawn Marie⋅Stull, Dawn Marie⋅Huang, Hui⋅Huang, Hui⋅Huang, Hui⋅Leleu, Xavier⋅Leleu, Xavier⋅Berdeja, Jesus⋅Berdeja, Jesus⋅Lee, Hans C⋅Lee, Hans C⋅Lee, Hans C⋅Weisel, Katja⋅Weisel, Katja⋅Thompson, Michael⋅Thompson, Michael⋅Thompson, Michael⋅Boccadoro, Mario⋅Boccadoro, Mario⋅Zonder, Jeffrey⋅Zonder, Jeffrey⋅Zonder, Jeffrey⋅Cook, Gordon⋅Cook, Gordon⋅Cook, Gordon⋅Puig, Noemi⋅Puig, Noemi⋅Vela-Ojeda, Jorge⋅Vela-Ojeda, Jorge⋅Vela-Ojeda, Jorge⋅Farrelly, Eileen⋅Farrelly, Eileen⋅Farrelly, Eileen⋅Raju, Aditya⋅Raju, Aditya⋅Blazer, Marlo⋅Blazer, Marlo⋅Chari, Ajai and Chari, AjaiAnnals of hematology, May 10, 2021.
| Journal Article
2020
A Prospective Phase II Clinical Trial of CD26/Dipeptidyl Peptidase (DPP)-IV Inhibition for Prevention of Acute Graft Versus Host Disease (aGVHD) Following Myeloablative Allogeneic Peripheral Blood Stem Cell (PBSC) TransplantationFarag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Nelson, Robert P⋅Nelson, Robert P⋅Nelson, Robert P⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Huntley, Carol⋅Huntley, Carol⋅Huntley, Carol⋅Blakley, Anne J⋅Blakley, Anne J⋅Blakley, Anne J⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Zhang, Shuhong⋅Zhang, Shuhong and Zhang, ShuhongBiology of Blood and Marrow Transplantation, vol. 26, (no. 3), pp. S28, March 2020.
| Journal Article
Connect MM Registry as a national reference for United States multiple myeloma patientsAilawadhi, Sikander⋅Jagannath, Sundar⋅Narang, Mohit⋅Rifkin, Robert M⋅Terebelo, Howard R⋅Toomey, Kathleen⋅Durie, Brian G. M⋅Hardin, James W⋅Gasparetto, Cristina J⋅Wagner, Lynne⋅Omel, James L⋅Kumar, Vivek⋅Yue, Lihua⋅Kitali, Amani⋅Agarwal, Amit and Abonour, RafatCancer Medicine, vol. 9, (no. 1), pp. 42, January 2020.
| Journal Article
High‐dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastasesKalra, Maitri⋅Kalra, Maitri⋅Kalra, Maitri⋅Kalra, Maitri⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H and Einhorn, Lawrence HCancer, vol. 126, (no. 6), pp. 1202-1207, Mar 2020.
| Journal Article
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trialsGavriatopoulou, Maria⋅Gavriatopoulou, Maria⋅Gavriatopoulou, Maria⋅Gavriatopoulou, Maria⋅Gavriatopoulou, Maria⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chari, Ajai⋅Chen, Christine⋅Chen, Christine⋅Chen, Christine⋅Chen, Christine⋅Chen, Christine⋅Bahlis, Nizar⋅Bahlis, Nizar⋅Bahlis, Nizar⋅Bahlis, Nizar⋅Vogl, Dan T⋅Vogl, Dan T⋅Vogl, Dan T⋅Vogl, Dan T⋅Vogl, Dan T⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Jakubowiak, Andrzej⋅Dingli, David⋅Dingli, David⋅Dingli, David⋅Dingli, David⋅Dingli, David⋅Cornell, Robert F⋅Cornell, Robert F⋅Cornell, Robert F⋅Cornell, Robert F⋅Cornell, Robert F⋅Hofmeister, Craig C⋅Hofmeister, Craig C⋅Hofmeister, Craig C⋅Hofmeister, Craig C⋅Hofmeister, Craig C⋅Siegel, David⋅Siegel, David⋅Siegel, David⋅Siegel, David⋅Siegel, David⋅Berdeja, Jesus G⋅Berdeja, Jesus G⋅Berdeja, Jesus G⋅Berdeja, Jesus G⋅Reece, Donna⋅Reece, Donna⋅Reece, Donna⋅Reece, Donna⋅Reece, Donna⋅White, Darrell⋅White, Darrell⋅White, Darrell⋅White, Darrell⋅White, Darrell⋅Lentzsch, Suzanne⋅Lentzsch, Suzanne⋅Lentzsch, Suzanne⋅Lentzsch, Suzanne⋅Lentzsch, Suzanne⋅Gasparetto, Cristina⋅Gasparetto, Cristina⋅Gasparetto, Cristina⋅Gasparetto, Cristina⋅Gasparetto, Cristina⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Huff, Carol Ann⋅Huff, Carol A⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Baz, Rachid⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Nooka, Ajay K⋅Richter, Joshua⋅Richter, Joshua⋅Richter, Joshua⋅Richter, Joshua⋅Richter, Joshua⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Parker, Terri L⋅Parker, Terri L⋅Parker, Terri L⋅Parker, Terri L⋅Parker, Terri L⋅Yee, Andrew J⋅Yee, Andrew J⋅Yee, Andrew J⋅Yee, Andrew J⋅Yee, Andrew J⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, Philippe⋅Moreau, Philippe⋅Lonial, Sagar⋅Lonial, Sagar⋅Lonial, Sagar⋅Lonial, Sagar⋅Tuchman, Sascha⋅Tuchman, Sascha⋅Tuchman, Sascha⋅Tuchman, Sascha⋅Weisel, Katja C⋅Weisel, Katja C⋅Weisel, Katja C⋅Weisel, Katja C⋅Weisel, Katja C⋅Mohty, Mohamad⋅Mohty, Mohamad⋅Mohty, Mohamad⋅Mohty, Mohamad⋅Choquet, Sylvain⋅Choquet, Sylvain⋅Choquet, Sylvain⋅Choquet, Sylvain⋅Unger, T J⋅Unger, T J⋅Unger, T J⋅Unger, T J⋅Unger, T J⋅Li, Kai⋅Li, Kai⋅Li, Kai⋅Li, Kai⋅Li, Kai⋅Chai, Yi⋅Chai, Yi⋅Chai, Yi⋅Chai, Yi⋅Chai, Yi⋅Li, Lingling⋅Li, Lingling⋅Li, Lingling⋅Li, Lingling⋅Li, Lingling⋅Shah, Jatin⋅Shah, Jatin⋅Shah, Jatin⋅Shah, Jatin⋅Shah, Jatin⋅Shacham, Sharon⋅Shacham, Sharon⋅Shacham, Sharon⋅Shacham, Sharon⋅Shacham, Sharon⋅Kauffman, Michael G⋅Kauffman, Michael G⋅Kauffman, Michael G⋅Kauffman, Michael G⋅Kauffman, Michael G⋅Dimopoulos, Meletios Athanasios⋅Dimopoulos, Meletios Athanasios⋅Dimopoulos, Meletios Athanasios and Dimopoulos, Meletios AthanasiosLeukemia, 2020-Feb-24.
| Journal Article
Prognostic significance of rate of tumor marker (TM) decline during high-dose chemotherapy (HDCT) for relapsed germ cell tumors (rGCT)Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Abu Zaid, Mohammad Issam⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Liu, Hao⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence and Einhorn, LawrenceJournal of Clinical Oncology, vol. 38, (no. 6_suppl), pp. 403, 2020-02-20.
| Journal Article
Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell TumorsZhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Zhang, Kevin Juan⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Hanna, Nasser H⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Althouse, Sandra K⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Albany, Costantine⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil⋅Adra, Nabil and Adra, NabilClinical Genitourinary Cancer, 2020-Feb-08.
| Journal Article
Treatment Journeys of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The Connect MM RegistryJagannath, Sundar⋅Rifkin, Robert M⋅Gasparetto, Cristina J⋅Toomey, Kathleen⋅Durie, Brian G.M⋅Hardin, James W⋅Terebelo, Howard R⋅Wagner, Lynne⋅Narang, Mohit⋅Ailawadhi, Sikander⋅Omel, James L⋅Srinivasan, Shankar⋅He, Mia⋅Ung, Brian⋅Kitali, Amani⋅Flick, E. Dawn⋅Agarwal, Amit and Abonour, RafatClinical Lymphoma, Myeloma and Leukemia, vol. 20, (no. 5), pp. 276, May 2020.
| Journal Article
2019
A Highly Robust Model for Predicting Outcome of Multiple Myeloma Patients By Inferring Patient-Specific Transcription Factor ActivityDong, Chuanpeng⋅Yu, Christina Y⋅Johnson, Travis S⋅Reiter, Jill L⋅Abu Zaid, Mohammad Issam⋅Abonour, Rafat⋅Roodman, G. David⋅Huang, Kun and Liu, YunlongBlood, vol. 134, (no. Supplement_1), pp. 1785, 2019-11-13.
| Journal Article
A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapyWeisel, Katja⋅Hungria, Vania⋅Leleu, Xavier⋅Lee, Hans⋅Rifkin, Robert⋅Costello, Caitlin⋅Abonour, Rafat⋅Chari, Ajai⋅Puig, Noemi⋅Berdeja, Jesus⋅Cook, Gordon⋅Thompson, Michael A⋅Boccadoro, Mario⋅Terpos, Evangelos⋅Zonder, Jeffrey A⋅Vela-Ojeda, Jorge⋅Davies, Faith⋅van Rhee, Frits⋅Hajek, Roman⋅Spencer, Andrew⋅Omel, Jim⋅Armour, Mira⋅Stull, Dawn Marie⋅Carlson, Gary⋅Elliott, Jennifer⋅Cherepanov, Dasha⋅Ferrari, Renda⋅Skacel, Tomas⋅Ren, Kaili and Usmani, SaadClinical Lymphoma, Myeloma and Leukemia, vol. 19, (no. 10), pp. e5, October 2019.
| Journal Article
Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect® MM RegistryWagner, Lynne I⋅Wagner, Lynne I.⋅Toomey, Kathleen⋅Toomey, Kathleen⋅Ailawadhi, Sikander⋅Ailawadhi, Sikander⋅Jagannath, Sundar⋅Jagannath, Sundar⋅Gasparetto, Cristina⋅Gasparetto, Cristina⋅Durie, Brian G.M⋅Durie, Brian G.M.⋅Narang, Mohit⋅Narang, Mohit⋅Rifkin, Robert M.⋅Rifkin, Robert M⋅Terebelo, Howard R.⋅Terebelo, Howard R⋅Omel, James L⋅Omel, James L.⋅Hardin, James W⋅Hardin, James W.⋅Lee, Hans C⋅Lee, Hans C.⋅Srinivasan, Shankar⋅Srinivasan, Shankar⋅Liu, Liang⋅Liu, Liang⋅Dhalla, Mazaher⋅Dhalla, Mazaher⋅Catamero, Donna⋅Catamero, Donna⋅Abonour, Rafat and Abonour, RafatBlood, vol. 134, (no. Supplement_1), pp. 1843, 2019-11-13.
| Journal Article
Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) in Routine Clinical Practice Remain Comparable to the Outcomes Reported in the Phase 3 Tourmaline-MM1 StudyHajek, Roman⋅Minarik, Jiri⋅Straub, Jan⋅Pour, Ludek⋅Jungova, Alexandra⋅Berdeja, Jesus G⋅Boccadoro, Mario⋅Brožová, Lucie⋅Spencer, Andrew⋅van Rhee, Frits⋅Vela-Ojeda, Jorge⋅Thompson, Michael A⋅Abonour, Rafat⋅Chari, Ajai⋅Cook, Gordon⋅Costello, Caitlin L⋅Davies, Faith E⋅Hungria, Vania T.M⋅Lee, Hans C⋅Leleu, Xavier⋅Puig, Noemi⋅Rifkin, Robert M⋅Terpos, Evangelos⋅Usmani, Saad Z⋅Weisel, Katja C⋅Zonder, Jeffrey A⋅Bařinová, Magda⋅Kuhn, Matyáš⋅Silar, Jiri⋅Capkova, Lenka⋅Galvez, Kenny⋅Lu, Jin⋅Skacel, Tomas⋅Elliott, Jennifer⋅Demers, Brittany⋅Stull, Dawn Marie⋅Ren, Kaili and Maisnar, VladimirBlood, vol. 134, (no. Supplement_1), pp. 1845, 2019-11-13.
| Journal Article
Development of a Novel Deep Transfer Learning Framework to Characterize Inter- and Intra-Tumor Heterogeneity in Myeloma PatientsJohnson, Travis S⋅Yu, Christina Y⋅Dong, Chuanpeng⋅Wang, Tongxin⋅Abu Zaid, Mohammad Issam⋅Abonour, Rafat⋅Roodman, G. David⋅Liu, Yunlong and Huang, KunBlood, vol. 134, (no. Supplement_1), pp. 3075, 2019-11-13.
| Journal Article
Development of a prognostic model for overall survival in multiple myeloma using the Connect® MM Patient RegistryTerebelo, Howard R⋅Abonour, Rafat⋅Gasparetto, Cristina J⋅Toomey, Kathleen⋅Durie, Brian G. M⋅Hardin, James W⋅Jagannath, Sundar⋅Wagner, Lynne⋅Narang, Mohit⋅Flick, E. Dawn⋅Srinivasan, Shankar⋅Yue, Lihua⋅Kitali, Amani⋅Agarwal, Amit and Rifkin, Robert MBritish Journal of Haematology, vol. 187, (no. 5), pp. 614, December 2019.
| Journal Article
Effect of t(11;14) on outcomes of patients (pts) with newly diagnosed multiple myeloma (NDMM) in the connect MM registryGasparetto, Cristina⋅Jagannath, Sundar⋅Rifkin, Robert M⋅Durie, Brian G⋅Narang, Mohit⋅Terebelo, Howard R⋅Toomey, Kathleen⋅Hardin, James W⋅Wagner, Lynne I⋅Ailawadhi, Sikander⋅Omel, James⋅Lee, Hans Chulhee⋅Srinivasan, Shankar⋅Dhalla, Mazaher⋅Catamero, Donna⋅Agarwal, Amit and Abonour, RafatJournal of Clinical Oncology, vol. 37, (no. 15_suppl), pp. 8032, 2019-05-20.
| Journal Article
Effect of t(11;14) on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM RegistryGasparetto, Cristina J⋅Jagannath, Sundar⋅Rifkin, Robert⋅Durie, Brian⋅Narang, Mohit⋅Terebelo, Howard⋅Toomey, Kathleen⋅Hardin, James⋅Wagner, Lynne⋅Ailawadhi, Sikander⋅Omel, Jim⋅Lee, Hans⋅Srinivasan, Shankar⋅Dhalla, Mazaher⋅Catamero, Donna⋅Agarwal, Amit and Abonour, RafatClinical Lymphoma, Myeloma and Leukemia, vol. 19, (no. 10), pp. e75, October 2019.
| Journal Article
Frequency of and Associations Amongst Baseline Cytogenetics in Patients With Newly Diagnosed Multiple Myeloma in the Connect® MM RegistryAilawadhi, Sikander⋅Gasparetto, Cristina J⋅Jagannath, Sundar⋅Rifkin, Robert⋅Durie, Brian⋅Narang, Mohit⋅Terebelo, Howard⋅Toomey, Kathleen⋅Hardin, James⋅Wagner, Lynne⋅Omel, Jim⋅Lee, Hans⋅Srinivasan, Shankar⋅He, Mia⋅Dhalla, Mazaher⋅Catamero, Donna⋅Bharadwaj, Anjali⋅Agarwal, Amit and Abonour, RafatClinical Lymphoma, Myeloma and Leukemia, vol. 19, (no. 10), pp. e75, October 2019.
| Journal Article
High-Dose Chemotherapy and Autologous Stem Cell Transplant.Adra, Nabil⋅Adra, Nabil⋅Abonour, Rafat, MD and Abonour, RafatThe Urologic clinics of North America, vol. 46, (no. 3), pp. 439-448, August 2019.
| Journal Article
High-Dose Thiotepa-Cyclophosphamide Results in Superior Outcomes Compared with Total Body Irradiation-Cyclophosphamide , Advanced Chronic Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell TransplantationHyder, Mustafa⋅Hyder, Mustafa⋅Hyder, Mustafa⋅Hyder, Mustafa⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Ervin, Kirsten⋅Ervin, Kirsten⋅Ervin, Kirsten⋅Ervin, Kirsten⋅Schmidt, Caitlin⋅Schmidt, Caitlin⋅Schmidt, Caitlin⋅Schmidt, Caitlin⋅Cox, Elizabeth⋅Cox, Elizabeth⋅Cox, Elizabeth⋅Cox, Elizabeth⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Nelson, Robert⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Schwartz, Jennifer⋅Zaid, Mohammad⋅Zaid, Mohammad⋅Zaid, Mohammad⋅Zaid, Mohammad⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Robertson, Michael⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Brinda, Bryan⋅Brinda, Bryan⋅Brinda, Bryan⋅Brinda, Bryan⋅Grove, Meagan⋅Grove, Meagan⋅Grove, Meagan⋅Grove, Meagan⋅Griffin, Shawn⋅Griffin, Shawn⋅Griffin, Shawn⋅Griffin, Shawn⋅Thakrar, Teresa⋅Thakrar, Teresa⋅Thakrar, Teresa⋅Thakrar, Teresa⋅Farag, Sherif⋅Farag, Sherif⋅Farag, Sherif and Farag, SherifBiology of Blood and Marrow Transplantation, vol. 25, (no. 3), pp. S192, 20190301.
| Journal Article
Higher Sirolimus Levels between Days 11-20 after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Increase the Risk of Hepatic Sinusuoidal Obstruction Syndrome (SOS) after Non-Busulfan Myeloablative ConditioningAgrawal, Vaibhav⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Agrawal, Vaibhav⋅Ranganath, Praveen⋅Ranganath, Praveen⋅Ranganath, Praveen⋅Ranganath, Praveen⋅Ervin, Kirsten D⋅Ervin, Kirsten D⋅Ervin, Kirsten D⋅Ervin, Kirsten D⋅Schmidt, Caitlin A⋅Schmidt, Caitlin A⋅Schmidt, Caitlin A⋅Schmidt, Caitlin A⋅Cox, Elizabeth A⋅Cox, Elizabeth A⋅Cox, Elizabeth A⋅Cox, Elizabeth A⋅Nelson, Robert P⋅Nelson, Robert P⋅Nelson, Robert P⋅Nelson, Robert P⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Schwartz, Jennifer E⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Zaid, Mohammad Abu⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Abonour, Rafat⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Robertson, Michael J⋅Brinda, Bryan J⋅Brinda, Bryan J⋅Brinda, Bryan J⋅Brinda, Bryan J⋅Griffin, Shawn P⋅Griffin, Shawn P⋅Griffin, Shawn P⋅Griffin, Shawn P⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Thakrar, Teresa C⋅Farag, Sherif S⋅Farag, Sherif S⋅Farag, Sherif S and Farag, Sherif SBiology of Blood and Marrow Transplantation, vol. 25, (no. 3), pp. S144, March 2019.
| Journal Article